Da det ikke er muligt at opnå denne dosis af fosamprenavir med tabletformuleringen, bør disse patienter behandles med fosamprenavir oral suspension.
As it is not possible to achieve this fosamprenavir dose using the tablet formulation, these patients should be treated with fosamprenavir oral suspension.